REDWOOD CITY, Calif., July 27, 2011 /PRNewswire/ — Genomic
Health, Inc. (Nasdaq:
GHDX) today announced that the company will host a conference
call and webcast on Wednesday, August 3 at 4:30 p.m. Eastern Time
to discuss its second quarter 2011 financial results. The
call and webcast will follow the release of the second quarter
financial results after market close.
Conference Call Details
To access the live conference call on August 3 at 4:30 p.m.
Eastern Time via phone, please dial (877) 303-7208 from the United
States and Canada or +1(224) 357-2389 internationally. Please
dial in approximately ten minutes prior to the start of the call.
A telephone replay will be available beginning approximately
two hours after the call through August 10, and may be accessed by
dialing (855) 859-2056 from the United States and Canada or +1(404)
537-3406 internationally. The replay passcode is
To access the live and subsequently archived webcast of the
conference call, go to the Investor Relations section of the
company’s Web site at http://investor.genomichealth.com.
Please connect to the web site at least 15 minutes prior to
the call to allow for any software download that may be
About Genomic Health
Genomic Health, Inc. (NASDAQ:
GHDX) is a molecular diagnostics company focused on the global
development and commercialization of genomic-based clinical
laboratory services that analyze the underlying biology of cancer
allowing physicians and patients to make individualized treatment
decisions. Its lead product, the Oncotype DX®
breast cancer test, has been shown to predict the likelihood of
chemotherapy benefit as well as recurrence in early-stage b